2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Argorna Pharmaceuticals Co., LTD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine Booster SARS-CoV-2 mRNA vaccine (RBMRNA-405), CoronaVac® - SARS-CoV-2 | Phase 1 | Completed | Argorna Pharmaceuticals Co., LTD | 60 | 2022-05-16 | 2024-03-25 |
| A Phase I/II Study to Evaluate a SARS-CoV-2 mRNA Vaccine in Healthy Adults RBMRNA-176, Placebo - SARS-CoV-2 | Phase 1 / Phase 2 | Completed | Argorna Pharmaceuticals Co., LTD | 480 | 2022-01-08 | 2024-01-10 |
CVnCoV COVID-19 vaccine (1) · sinovac COVID-19 vaccine (1)
China (2)